Enterprise record

InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0Version: public-1As of: unavailable

10 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 30, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 30, 2026

    Supports 3 claims
    • Legal Name: InMed Pharmaceuticals Inc. · Claim reviewed: Sep 30, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 30, 2026
    • Published Fact: US · Claim reviewed: Sep 30, 2026

  2. InMed Pharmaceuticals Inc. DEF 14A 2025-11-03

    sec proxy · Source published: Nov 3, 2025 · Retrieved: Apr 28, 2026

    Supports 5 claims
    • Leadership Role: Andrew Hull: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Eric A. Adams: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: John Bathery: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Neil Klompas: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Nicole Lemerond: Director · Claim reviewed: Sep 30, 2026

  3. INM 10-K executive officers

    sec filing · Source published: Sep 23, 2025 · Retrieved: May 16, 2026

    Supports 2 claims
    • Leadership Role: Eric A. Adams: President, Chief Executive Officer and Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Netta Jagpal: Chief Financial Officer · Claim reviewed: Sep 30, 2026